A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Clinical trial NCT00570986 · COMPLETED
Trial details
- NCT number
- NCT00570986
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-06-01
- Enrollment
- 1465
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.